|
US20060106020A1
(en)
*
|
2004-04-28 |
2006-05-18 |
Rodgers James D |
Tetracyclic inhibitors of Janus kinases
|
|
SI1966202T1
(sl)
|
2005-12-13 |
2012-01-31 |
Incyte Corp |
S heteroarilom substituirani pirolo (2,3-b)piridini in pirolo (2,3-b)pirimidini kot zaviralci janus kinaze
|
|
EP2121692B1
(en)
|
2006-12-22 |
2013-04-10 |
Incyte Corporation |
Substituted heterocycles as janus kinase inhibitors
|
|
CL2008001709A1
(es)
|
2007-06-13 |
2008-11-03 |
Incyte Corp |
Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
|
|
EP2173752B2
(en)
|
2007-06-13 |
2022-07-13 |
Incyte Holdings Corporation |
Salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
|
|
FR2938537B1
(fr)
|
2008-11-14 |
2012-10-26 |
Sanofi Aventis |
Derives de carbamates d'alkyl-heterocycles, leur preparation et leur application en therapeutique.
|
|
JOP20190230A1
(ar)
|
2009-01-15 |
2017-06-16 |
Incyte Corp |
طرق لاصلاح مثبطات انزيم jak و المركبات الوسيطة المتعلقة به
|
|
CN106967070A
(zh)
|
2009-05-22 |
2017-07-21 |
因塞特控股公司 |
作为jak抑制剂的化合物
|
|
CA2762174C
(en)
|
2009-05-22 |
2018-02-20 |
Incyte Corporation |
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
|
AR078012A1
(es)
|
2009-09-01 |
2011-10-05 |
Incyte Corp |
Derivados heterociclicos de las pirazol-4-il- pirrolo (2,3-d) pirimidinas como inhibidores de la quinasa janus
|
|
US20110207736A1
(en)
*
|
2009-12-23 |
2011-08-25 |
Gatekeeper Pharmaceuticals, Inc. |
Compounds that modulate egfr activity and methods for treating or preventing conditions therewith
|
|
AU2011214254B2
(en)
*
|
2010-02-10 |
2016-06-09 |
Genon Biotechnologies Oy |
Dual activity kinase domains and uses thereof
|
|
JP5858434B2
(ja)
*
|
2010-02-18 |
2016-02-10 |
インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ |
Ｊａｎｕｓキナーゼ阻害薬としてのシクロブタンおよびメチルシクロブタン誘導体
|
|
EP3715347B1
(en)
|
2010-03-10 |
2021-12-22 |
Incyte Holdings Corporation |
Piperidin-4-yl azetidine derivatives as jak1 inhibitors
|
|
GB201007286D0
(en)
*
|
2010-04-30 |
2010-06-16 |
Astex Therapeutics Ltd |
New compounds
|
|
NZ603686A
(en)
|
2010-05-21 |
2014-11-28 |
Incyte Corp |
Topical formulation for a jak inhibitor
|
|
PT2576541T
(pt)
|
2010-06-04 |
2016-07-08 |
Hoffmann La Roche |
Derivados de aminopirimidina como moduladores de lrrk2
|
|
CA2815330A1
(en)
*
|
2010-11-09 |
2012-05-18 |
Cellzome Limited |
Pyridine compounds and aza analogues thereof as tyk2 inhibitors
|
|
CA2812669C
(en)
|
2010-11-10 |
2018-11-06 |
F. Hoffmann-La Roche Ag |
Pyrazole aminopyrimidine derivatives as lrrk2 modulators
|
|
JP5917544B2
(ja)
|
2010-11-19 |
2016-05-18 |
インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ |
Ｊａｋ阻害剤としての複素環置換ピロロピリジンおよびピロロピリミジン
|
|
PE20140146A1
(es)
|
2010-11-19 |
2014-02-06 |
Incyte Corp |
Derivados de pirrolopiridina y pirrolopirimidina sustituidos con ciclobutilo como inhibidores de jak
|
|
GB201020179D0
(en)
|
2010-11-29 |
2011-01-12 |
Astex Therapeutics Ltd |
New compounds
|
|
JP5936628B2
(ja)
|
2011-02-18 |
2016-06-22 |
ノバルティス・ファルマ・アクチェンゲゼルシャフトＮｏｖａｒｔｉｓ Ｐｈａｒｍａ ＡＧ |
ｍＴＯＲ／ＪＡＫ阻害剤併用療法
|
|
US9284298B2
(en)
*
|
2011-04-11 |
2016-03-15 |
Nerviano Medical Sciences S.R.L. |
Pyrazolyl-pyrimidine derivatives as kinase inhibitors
|
|
TWI577676B
(zh)
|
2011-06-20 |
2017-04-11 |
英塞特控股公司 |
作為ｊａｋ抑制劑之吖丁啶基苯基、吡啶基或吡基羧醯胺衍生物
|
|
EP2741747A1
(en)
|
2011-08-10 |
2014-06-18 |
Novartis Pharma AG |
JAK P13K/mTOR COMBINATION THERAPY
|
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
|
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
|
EP2758377B1
(en)
*
|
2011-09-22 |
2017-08-02 |
Merck Sharp & Dohme Corp. |
Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors
|
|
GB201118675D0
(en)
|
2011-10-28 |
2011-12-14 |
Astex Therapeutics Ltd |
New compounds
|
|
GB201118656D0
(en)
|
2011-10-28 |
2011-12-07 |
Astex Therapeutics Ltd |
New compounds
|
|
GB201118652D0
(en)
|
2011-10-28 |
2011-12-07 |
Astex Therapeutics Ltd |
New compounds
|
|
GB201118654D0
(en)
|
2011-10-28 |
2011-12-07 |
Astex Therapeutics Ltd |
New compounds
|
|
CN103102359B
(zh)
*
|
2011-11-15 |
2016-11-09 |
江苏先声药业有限公司 |
嘧啶类化合物及其应用
|
|
WO2013082476A1
(en)
|
2011-11-30 |
2013-06-06 |
Emory University |
Antiviral jak inhibitors useful in treating or preventing retroviral and other viral infections
|
|
TW201406761A
(zh)
|
2012-05-18 |
2014-02-16 |
Incyte Corp |
做爲ｊａｋ抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物
|
|
GB201209609D0
(en)
|
2012-05-30 |
2012-07-11 |
Astex Therapeutics Ltd |
New compounds
|
|
GB201209613D0
(en)
|
2012-05-30 |
2012-07-11 |
Astex Therapeutics Ltd |
New compounds
|
|
KR20150034209A
(ko)
|
2012-06-26 |
2015-04-02 |
델 마 파마슈티컬스 인코포레이티드 |
디안하이드로갈락티톨, 디아세틸디안하이드로갈락티톨, 디브로모둘시톨, 또는 그의 유사체 또는 유도체를 이용하여 유전학적 다형성이 있는 환자에 있어서 티로신-키나아제-억제제 내성 악성종양, ahi1 조절곤란 또는 돌연변이를 치료하는 방법
|
|
US8809359B2
(en)
*
|
2012-06-29 |
2014-08-19 |
Ym Biosciences Australia Pty Ltd |
Phenyl amino pyrimidine bicyclic compounds and uses thereof
|
|
WO2014066196A1
(en)
*
|
2012-10-23 |
2014-05-01 |
Merck Sharp & Dohme Corp. |
2-pyridyloxy-3-substituted-4-nitrile orexin receptor antagonists
|
|
MX2015005428A
(es)
|
2012-11-01 |
2015-07-21 |
Incyte Corp |
Derivados triciclicos fusionados de tiofeno como inhibidores de la cinasa janus (jak).
|
|
US9499539B2
(en)
*
|
2012-11-05 |
2016-11-22 |
Nantbioscience, Inc. |
Cyclic sulfonamide containing derivatives as inhibitors of hedgehog signaling pathway
|
|
SG11201503695XA
(en)
|
2012-11-15 |
2015-06-29 |
Incyte Corp |
Sustained-release dosage forms of ruxolitinib
|
|
WO2014075318A1
(zh)
*
|
2012-11-19 |
2014-05-22 |
江苏先声药业有限公司 |
嘧啶类化合物及其应用
|
|
JP6412503B2
(ja)
|
2012-11-21 |
2018-10-24 |
ピーティーシー セラピューティクス， インコーポレイテッド |
置換逆ピリミジンＢｍｉ−１阻害剤
|
|
JP6397831B2
(ja)
*
|
2013-03-06 |
2018-09-26 |
インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ |
Ｊａｋ阻害剤の製造方法及びその中間体
|
|
WO2014146249A1
(en)
*
|
2013-03-19 |
2014-09-25 |
Merck Sharp & Dohme Corp. |
Geminally substituted cyanoethylpyrazolo pyridones as janus kinase inhibitors
|
|
GB201307577D0
(en)
|
2013-04-26 |
2013-06-12 |
Astex Therapeutics Ltd |
New compounds
|
|
WO2014186706A1
(en)
*
|
2013-05-17 |
2014-11-20 |
Incyte Corporation |
Bipyrazole derivatives as jak inhibitors
|
|
EP3004057B1
(en)
*
|
2013-06-05 |
2018-07-25 |
C&C Research Laboratories |
Heterocyclic derivatives and their use as stat 3 inhibitors
|
|
UA120499C2
(uk)
|
2013-08-07 |
2019-12-26 |
Інсайт Корпорейшн |
Лікування захворювань із застосуванням лікарських форм з уповільненим вивільненням для інгібітора jak1
|
|
CA2922657C
(en)
*
|
2013-08-30 |
2022-04-12 |
Ptc Therapeutics, Inc. |
Substituted pyrimidine bmi-1 inhibitors
|
|
WO2015067630A1
(de)
|
2013-11-08 |
2015-05-14 |
Bayer Pharma Aktiengesellschaft |
Substituierte uracile und ihre verwendung
|
|
EP3071553A4
(en)
|
2013-11-21 |
2017-08-02 |
PTC Therapeutics, Inc. |
Substituted pyridine and pyrazine bmi-1 inhibitors
|
|
CN104860941B
(zh)
*
|
2014-02-25 |
2017-03-22 |
上海海雁医药科技有限公司 |
2,4‑二取代苯‑1,5‑二胺衍生物及其应用以及由其制备的药物组合物和药用组合物
|
|
RU2715893C2
(ru)
|
2014-03-26 |
2020-03-04 |
Астекс Терапьютикс Лтд |
Комбинации ингибитора fgfr и ингибитора igf1r
|
|
SMT202100115T1
(it)
|
2014-03-26 |
2021-05-07 |
Astex Therapeutics Ltd |
Combinazioni di inibitori di fgfr e cmet per il trattamento del cancro
|
|
JO3512B1
(ar)
|
2014-03-26 |
2020-07-05 |
Astex Therapeutics Ltd |
مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
|
|
JP2017514832A
(ja)
|
2014-04-30 |
2017-06-08 |
インサイト・コーポレイションＩｎｃｙｔｅ Ｃｏｒｐｏｒａｔｉｏｎ |
Ｊａｋ１抑制剤を調製する方法及びその新しい形態
|
|
WO2015184305A1
(en)
|
2014-05-30 |
2015-12-03 |
Incyte Corporation |
TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1
|
|
WO2016105525A2
(en)
*
|
2014-12-23 |
2016-06-30 |
Dana-Farber Cancer Institute, Inc. |
Novel pyrimidines as egfr inhibitors and methods of treating disorders
|
|
JOP20200201A1
(ar)
|
2015-02-10 |
2017-06-16 |
Astex Therapeutics Ltd |
تركيبات صيدلانية تشتمل على n-(3.5- ثنائي ميثوكسي فينيل)-n'-(1-ميثيل إيثيل)-n-[3-(ميثيل-1h-بيرازول-4-يل) كينوكسالين-6-يل]إيثان-1.2-ثنائي الأمين
|
|
US10478494B2
(en)
|
2015-04-03 |
2019-11-19 |
Astex Therapeutics Ltd |
FGFR/PD-1 combination therapy for the treatment of cancer
|
|
EP3327014A4
(en)
*
|
2015-07-24 |
2019-01-02 |
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. |
Egfr inhibitor and pharmaceutically acceptable salt and polymorph thereof, and use thereof
|
|
LT3353177T
(lt)
|
2015-09-23 |
2020-08-25 |
Janssen Pharmaceutica Nv |
Tricikliniai heterociklai, skirti vėžio gydymui
|
|
MX378230B
(es)
|
2015-09-23 |
2025-03-10 |
Janssen Pharmaceutica Nv |
1,4-benzodiazepinas biheteroarilo sustituidas y usos de las mismas para el tratamiento del cáncer.
|
|
TWI720269B
(zh)
*
|
2016-11-22 |
2021-03-01 |
財團法人生物技術開發中心 |
用於調節刺蝟途徑之雜芳基胺化合物及其製法及用途
|
|
MD3697789T2
(ro)
|
2017-10-18 |
2022-02-28 |
Incyte Corp |
Derivați imidazol condensați substituiți cu grupări hidroxi terțiare ca inhibitori PI3K-GAMA
|
|
WO2019113487A1
(en)
|
2017-12-08 |
2019-06-13 |
Incyte Corporation |
Low dose combination therapy for treatment of myeloproliferative neoplasms
|
|
MD3746429T2
(ro)
|
2018-01-30 |
2022-08-31 |
Incyte Corp |
Procedee pentru prepararea de (1-(3-fluoro-2-(trifluorometil)izonicotinil)piperidin-4-onă)
|
|
BR112020016628A2
(pt)
|
2018-02-16 |
2020-12-15 |
Incyte Corporation |
Inibidores da via de jak1 para o tratamento de distúrbios relacionados a citocinas
|
|
HUE067471T2
(hu)
|
2018-03-30 |
2024-10-28 |
Incyte Corp |
Gennyes verejtékmirigy-gyulladás kezelése jak inhibitorok alkalmazásával
|
|
WO2019191679A1
(en)
|
2018-03-30 |
2019-10-03 |
Incyte Corporation |
Biomarkers for inflammatory skin disease
|
|
CN112567247A
(zh)
|
2018-04-13 |
2021-03-26 |
因赛特公司 |
用于移植物抗宿主病的生物标志物
|
|
BR112021002630A2
(pt)
|
2018-08-17 |
2021-05-11 |
Ptc Therapeutics, Inc. |
método para tratar câncer pancreático
|
|
CR20250050A
(es)
|
2018-09-05 |
2025-03-19 |
Incyte Corp |
Formas cristalinas de un inhibidor de fosfoinositida 3–quinasa (pi3k) (divisional 2021-0165)
|
|
US11066404B2
(en)
|
2018-10-11 |
2021-07-20 |
Incyte Corporation |
Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
|
|
EP3870177A1
(en)
*
|
2018-10-26 |
2021-09-01 |
Arrien Pharmaceuticals LLC |
Pyrazolyl compounds and methods of use thereof
|
|
IL282643B2
(en)
|
2018-10-31 |
2025-08-01 |
Incyte Corp |
A selective jak1 inhibitor for use in a method of treating hematological disease
|
|
WO2020118683A1
(en)
*
|
2018-12-14 |
2020-06-18 |
Lynk Pharmaceuticals Co. Ltd. |
Benzamides of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof
|
|
WO2020168197A1
(en)
|
2019-02-15 |
2020-08-20 |
Incyte Corporation |
Pyrrolo[2,3-d]pyrimidinone compounds as cdk2 inhibitors
|
|
WO2020180959A1
(en)
|
2019-03-05 |
2020-09-10 |
Incyte Corporation |
Pyrazolyl pyrimidinylamine compounds as cdk2 inhibitors
|
|
WO2020205560A1
(en)
|
2019-03-29 |
2020-10-08 |
Incyte Corporation |
Sulfonylamide compounds as cdk2 inhibitors
|
|
EP3956330A4
(en)
|
2019-04-18 |
2023-01-18 |
The Johns Hopkins University |
SUBSTITUTED 2-AMINO-PYRAZOLYL-[1,2,4]TRIAZOLO[1,5A]PYRIDINE DERIVATIVES AND THEIR USE
|
|
WO2020223558A1
(en)
|
2019-05-01 |
2020-11-05 |
Incyte Corporation |
Tricyclic amine compounds as cdk2 inhibitors
|
|
WO2020223469A1
(en)
|
2019-05-01 |
2020-11-05 |
Incyte Corporation |
N-(1-(methylsulfonyl)piperidin-4-yl)-4,5-di hydro-1h-imidazo[4,5-h]quinazolin-8-amine derivatives and related compounds as cyclin-dependent kinase 2 (cdk2) inhibitors for treating cancer
|
|
US12428394B2
(en)
|
2019-06-28 |
2025-09-30 |
Chengdu Zenitar Biomedical Technology Co., Ltd. |
2,4-disubstituted pyrimidine derivative, preparation method therefor and use thereof
|
|
CN112142731B
(zh)
*
|
2019-06-28 |
2022-07-22 |
成都赜灵生物医药科技有限公司 |
一种2，4-二取代嘧啶衍生物及其制备方法和用途
|
|
TW202115024A
(zh)
|
2019-08-14 |
2021-04-16 |
美商英塞特公司 |
作為cdk2 抑制劑之咪唑基嘧啶基胺化合物
|
|
JP2022549506A
(ja)
|
2019-09-27 |
2022-11-25 |
ディスク・メディシン・インコーポレイテッド |
骨髄線維症および関連状態を処置するための方法
|
|
US12203942B2
(en)
|
2019-10-10 |
2025-01-21 |
Incyte Corporation |
Biomarkers for graft-versus-host disease
|
|
US12360120B2
(en)
|
2019-10-10 |
2025-07-15 |
Incyte Corporation |
Biomarkers for graft-versus-host disease
|
|
PE20221905A1
(es)
|
2019-10-11 |
2022-12-23 |
Incyte Corp |
Aminas biciclicas como inhibidoras de la cdk2
|
|
PE20230251A1
(es)
|
2019-11-22 |
2023-02-07 |
Incyte Corp |
Terapia de combinacion que comprende un inhibidor de alk2 y un inhibidor de jak2
|
|
CN115413278B
(zh)
*
|
2020-03-23 |
2025-01-10 |
丸仁制药株式会社 |
新型嘧啶衍生物以及包含其的神经退行性疾病和癌症的预防或治疗用组合物
|
|
CN115836089A
(zh)
|
2020-05-13 |
2023-03-21 |
迪斯克医药公司 |
用于治疗骨髓纤维化的抗血幼素（hjv）抗体
|
|
FI4157831T3
(fi)
|
2020-06-02 |
2024-12-02 |
Incyte Corp |
Menetelmiä jak1-estäjän valmistamiseksi
|
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
|
AU2021329301A1
(en)
|
2020-08-18 |
2023-04-13 |
Incyte Corporation |
Process and intermediates for preparing a JAK1 inhibitor
|
|
IL300555A
(en)
|
2020-08-18 |
2023-04-01 |
Incyte Corp |
Process and intermediates for preparing a JAK inhibitor
|
|
CN114181199B
(zh)
*
|
2020-09-15 |
2023-09-26 |
成都赜灵生物医药科技有限公司 |
2，4-二取代嘧啶衍生物及其制备方法和用途
|
|
CN112142675B
(zh)
*
|
2020-10-09 |
2021-11-30 |
嘉兴特科罗生物科技有限公司 |
一种作为jak激酶抑制剂的小分子化合物及其用途
|
|
CN112159394B
(zh)
*
|
2020-10-09 |
2021-10-22 |
嘉兴特科罗生物科技有限公司 |
一种作为jak激酶抑制剂的小分子化合物及其用途
|
|
US11957661B2
(en)
|
2020-12-08 |
2024-04-16 |
Incyte Corporation |
JAK1 pathway inhibitors for the treatment of vitiligo
|
|
WO2022166916A1
(zh)
*
|
2021-02-05 |
2022-08-11 |
深圳市塔吉瑞生物医药有限公司 |
取代的杂芳基衍生物及其组合物及用途
|
|
LT4333840T
(lt)
|
2021-05-03 |
2026-01-12 |
Incyte Corporation |
Jak1 kelio inhibitoriai, skirti mazgelinio niežulio gydymui
|
|
US11981671B2
(en)
|
2021-06-21 |
2024-05-14 |
Incyte Corporation |
Bicyclic pyrazolyl amines as CDK2 inhibitors
|
|
US12071439B2
(en)
|
2021-07-12 |
2024-08-27 |
Incyte Corporation |
Process and intermediates for preparing a JAK inhibitor
|
|
WO2023060202A1
(en)
*
|
2021-10-06 |
2023-04-13 |
Aerie Pharmaceuticals, Inc. |
Janus kinase inhibiting pyrazole compounds and uses thereof
|
|
US11976073B2
(en)
|
2021-12-10 |
2024-05-07 |
Incyte Corporation |
Bicyclic amines as CDK2 inhibitors
|
|
KR20250051678A
(ko)
*
|
2022-08-22 |
2025-04-17 |
항저우 하이라이트엘엘 파마슈티컬 씨오., 엘티디. |
피부과 질환의 국소 치료를 위한 jak1/jak2/tyk2 억제제
|
|
CN115594664B
(zh)
*
|
2022-11-25 |
2023-02-24 |
英矽智能科技(上海)有限公司 |
一类螺环衍生物作为kif18a抑制剂
|